Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 8/2011

01-08-2011 | Erratum

Erratum to: When the treatment goal is not cure: are patients informed adequately?

Authors: Martin H. Tattersall, Melina Gattellari, Katie Voigt, Phyllis N. Butow

Published in: Supportive Care in Cancer | Issue 8/2011

Login to get access

Excerpt

Erratum to: Support Care Cancer …
Metadata
Title
Erratum to: When the treatment goal is not cure: are patients informed adequately?
Authors
Martin H. Tattersall
Melina Gattellari
Katie Voigt
Phyllis N. Butow
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1198-5

Other articles of this Issue 8/2011

Supportive Care in Cancer 8/2011 Go to the issue

Review Article

Facilitating the implementation of empirically valid interventions in psychosocial oncology and supportive care

Original Article

Activism among exceptional patients with cancer

Short Communication

Decisions for lung cancer chemotherapy: the influence of physician and patient factors

Original Article

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy

Original Article

Enhancing decision making about participation in cancer clinical trials: development of a question prompt list

Original Article

Views of psycho-oncology health professionals on priority psycho-oncology research questions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits